Research Focus

Former Employee. Medicine; Clinical Research Manager

Recent additions – View all

1. ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

   Journal Article

   Matulonis, U. A.; Lee, J.; Lasonde, B.; Tew, W. P.; Yehwalashet, A.; Matei, D.; Behbakht, K.; Grothusen, J.; Fleming, G.; Lee, N. K.; more...
   European Journal of Cancer (2013)

   Fulltext@MSK | Save